Insiders · Profile

RAY DEBANJAN

Chief Financial Officer at CytomX Therapeutics. Filing since 3 Jul 2017. CIK 0001706863

Company

Date

Role

Action

Shares

Amount

Of holding

CTMX CytomX Therapeutics, Inc.

12 Dec 2018

Chief Financial Officer

Sold, plan not stated

3,000

$45.00K

33.6%

CTMX CytomX Therapeutics, Inc.

1 Nov 2018

Chief Financial Officer

Sold, plan not stated

3,000

$45.00K

33.6%

CTMX CytomX Therapeutics, Inc.

1 Oct 2018

Chief Financial Officer

Sold, plan not stated

3,000

$55.38K

33.6%

CTMX CytomX Therapeutics, Inc.

4 Sep 2018

Chief Financial Officer

Sold, plan not stated

3,000

$67.17K

33.6%

CTMX CytomX Therapeutics, Inc.

1 Aug 2018

Chief Financial Officer

Sold, plan not stated

3,000

$78.15K

33.6%

CTMX CytomX Therapeutics, Inc.

2 Jul 2018

Chief Financial Officer

Sold, plan not stated

3,000

$67.68K

33.6%

CTMX CytomX Therapeutics, Inc.

1 Jun 2018

Chief Financial Officer

Sold, plan not stated

3,000

$77.79K

33.6%

CTMX CytomX Therapeutics, Inc.

1 May 2018

Chief Financial Officer

Sold, plan not stated

3,000

$79.56K

38.8%

CTMX CytomX Therapeutics, Inc.

2 Apr 2018

Chief Financial Officer

Sold, plan not stated

3,000

$84.36K

38.8%

CTMX CytomX Therapeutics, Inc.

2 Mar 2018

Chief Financial Officer

Sold, plan not stated

20,000

$607.45K

80.8%

CTMX CytomX Therapeutics, Inc.

1 Mar 2018

Chief Financial Officer

Sold, plan not stated

13,000

$382.24K

73.3%

CTMX CytomX Therapeutics, Inc.

1 Feb 2018

Chief Financial Officer

Sold, plan not stated

2,548

$68.01K

35.0%

CTMX CytomX Therapeutics, Inc.

2 Jan 2018

Chief Financial Officer

Sold, plan not stated

2,500

$52.78K

25.5%

CTMX CytomX Therapeutics, Inc.

1 Dec 2017

Chief Financial Officer

Sold, plan not stated

2,500

$51.45K

20.3%

CTMX CytomX Therapeutics, Inc.

1 Nov 2017

Chief Financial Officer

Sold, plan not stated

2,500

$50.00K

17.1%

CTMX CytomX Therapeutics, Inc.

2 Oct 2017

Chief Financial Officer

Sold, plan not stated

2,500

$45.25K

14.6%

CTMX CytomX Therapeutics, Inc.

1 Sep 2017

Chief Financial Officer

Sold, plan not stated

2,500

$42.93K

12.7%

CTMX CytomX Therapeutics, Inc.

9 Aug 2017

Chief Financial Officer

Sold, plan not stated

2,500

$37.50K

11.3%

CTMX CytomX Therapeutics, Inc.

3 Jul 2017

Chief Financial Officer

Sold, plan not stated

2,500

$38.68K

10.2%

19 decisions on file.